Organisation paid for research Program year 2025 Source: CMS Open Payments

Urology Austin

Neither a doctor nor a teaching hospital

Research payments

$300,114

2 payments

Through program year 2025, Urology Austin is reported as receiving $300,114 in research payments, across 2 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$35,000	1
2024	Research	$265,114	1

Breakdown

Who paid Research payments · program years 2024–2025

AstraZeneca Pharmaceuticals LP $265,114 1 payment
E.R. Squibb & Sons, L.L.C. $35,000 1 payment

Studies the money was for Research payments · program years 2024–2025

a phase 3b,open label,single arm,multi center,US study of bacillus calmette guerin bcg administered in combination with durvalumab in adult bcg naive,high risk non muscle invasive bladder cancer participants patapsco $265,114 1 payment
A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 versus Investigators Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge $35,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.